STOCK TITAN

InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

InnovAge Holding Corp (Nasdaq: INNV) announces key leadership changes effective November 4th, 2024. Michael Scarbrough joins as President and Chief Operating Officer, replacing Christine Bent who is stepping down. Scarbrough brings over 30 years of healthcare experience, most recently serving as CEO of Optum at Home. Additionally, Maria Lozzano is promoted to President, Pharmacy Services. Lozzano previously served as Senior Vice President and Chief Business Development Operations Officer at InnovAge. The company, which manages care for dual-eligible seniors through PACE programs, currently serves approximately 7,020 participants across 20 centers in six states.

InnovAge Holding Corp (Nasdaq: INNV) annuncia importanti cambiamenti nella leadership a partire dal 4 novembre 2024. Michael Scarbrough entra come Presidente e Direttore Operativo, sostituendo Christine Bent che si dimette. Scarbrough porta con sé oltre 30 anni di esperienza nel settore sanitario, avendo ricoperto recentemente il ruolo di CEO di Optum at Home. Inoltre, Maria Lozzano è promossa a Presidente dei Servizi Farmaceutici. Lozzano ha precedentemente ricoperto il ruolo di Vicepresidente Senior e Direttore delle Operazioni di Sviluppo Aziendale presso InnovAge. L'azienda gestisce la cura per gli anziani dualmente idonei attraverso i programmi PACE e attualmente serve circa 7.020 partecipanti in 20 centri in sei stati.

InnovAge Holding Corp (Nasdaq: INNV) anuncia cambios clave en el liderazgo que entrarán en vigor el 4 de noviembre de 2024. Michael Scarbrough se une como Presidente y Director de Operaciones, reemplazando a Christine Bent, quien dejará su cargo. Scarbrough aporta más de 30 años de experiencia en atención médica, habiendo sido más recientemente CEO de Optum at Home. Además, Maria Lozzano es promovida a Presidenta de Servicios de Farmacia. Lozzano se había desempeñado anteriormente como Vicepresidenta Senior y Directora de Operaciones de Desarrollo de Negocios en InnovAge. La compañía gestiona la atención de ancianos con doble elegibilidad a través de los programas PACE, sirviendo actualmente a aproximadamente 7,020 participantes en 20 centros en seis estados.

InnovAge Holding Corp (Nasdaq: INNV)는 2024년 11월 4일부터 시행되는 주요 리더십 변화를 발표했습니다. Michael Scarbrough가 회장 겸 COO로 합류하며, Christine Bent가 물러납니다. Scarbrough는 30년 이상의 의료 경험을 보유하고 있으며, 최근에는 Optum at Home의 CEO로 재직했습니다. 또한, Maria Lozzano는 약국 서비스의 회장으로 승진했습니다. Lozzano는 이전에 InnovAge의 선임 부사장 및 사업 개발 운영 책임자로 재직했습니다. 이 회사는 PACE 프로그램을 통해 이중 자격을 갖춘 노인의 돌봄을 관리하며, 현재 6개 주의 20개 센터에서 약 7,020명의 참가자를 지원하고 있습니다.

InnovAge Holding Corp (Nasdaq: INNV) annonce d'importants changements de leadership à compter du 4 novembre 2024. Michael Scarbrough rejoint l'entreprise en tant que Président et Directeur des opérations, remplaçant Christine Bent qui quitte ses fonctions. Scarbrough apporte plus de 30 ans d'expérience dans le secteur de la santé, ayant récemment été PDG d'Optum at Home. De plus, Maria Lozzano est promue Présidente des Services Pharmaceutiques. Lozzano a précédemment occupé le poste de Vice-Présidente Senior et Directrice des opérations de développement commercial chez InnovAge. L'entreprise gère la prise en charge des seniors éligibles à double statut à travers des programmes PACE et sert actuellement environ 7 020 participants dans 20 centres répartis dans six États.

InnovAge Holding Corp (Nasdaq: INNV) kündigt bedeutende Führungswechsel an, die am 4. November 2024 wirksam werden. Michael Scarbrough tritt als Präsident und Chief Operating Officer bei, und ersetzt Christine Bent, die zurücktritt. Scarbrough bringt über 30 Jahre Erfahrung im Gesundheitswesen mit und war zuletzt CEO von Optum at Home. Außerdem wurde Maria Lozzano zur Präsidentin der Apothekenservices befördert. Lozzano war zuvor Senior Vice President und Chief Business Development Operations Officer bei InnovAge. Das Unternehmen, das die Pflege für dual berechtigte Senioren über PACE-Programme verwaltet, betreut derzeit etwa 7.020 Teilnehmer in 20 Zentren in sechs Bundesstaaten.

Positive
  • Appointment of experienced healthcare executive with 30+ years of expertise in operational leadership
  • New executive brings specific experience in Medicare Advantage D-SNP and Medicaid programs
  • Internal promotion for Pharmacy Services leadership indicates strong succession planning
Negative
  • Departure of current COO could create temporary operational disruption
  • Separation of President and CEO roles adds additional layer to management structure

DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th.

Mr. Scarbrough joins InnovAge’s executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable execution of strategic priorities.

The InnovAge team extends its gratitude to Ms. Bent for her exceptional service and numerous contributions, which have helped drive a more scalable infrastructure and positive participant experience.

“Michael’s operational background and deep experience in healthcare is a great fit for InnovAge as we continue to evolve our business and to serve more seniors,” said Patrick Blair, CEO. “Michael brings more than 30 years of healthcare experience at both established and scaling businesses, including executive operational leadership, payor and provider network development, and government programs expertise. Michael has worked with numerous states in the last 15 years as they transitioned various Medicaid populations into new care delivery models that expanded participant choice, improved quality, lowered costs, and increased patient satisfaction.”

Mr. Scarbrough brings more than three decades of healthcare experience to InnovAge, most recently serving as the Chief Executive Officer of Optum at Home, a division of Optum Health, responsible for services to 800,000 Medicare Advantage D-SNP members. Prior to Optum at Home, Scarbrough was a co-founder and served as the President and COO of Prospero Health, serving over 50,000 patients. Prospero was created to provide home-based advanced primary, urgent, and palliative care services and was sold to Optum in 2022. Earlier in his career, Scarbrough was SVP, Medicaid Development & Specialty at Anthem, SVP of Health Care Delivery Systems at Amerigroup, and the COO of Amerigroup Tennessee.

Additionally, Ms. Lozzano is being promoted to President, Pharmacy Services, and will report to the CEO. Ms. Lozzano most recently served as the Company’s Senior Vice President and Chief Business Development Operations Officer supporting existing center performance improvement and new center market expansions. Maria joined Innovage from the VNA of California where she served as Chief Operating Officer. Prior to that, she worked as Vice President of Operations at Premier Infusion Care, a provider of home infusion and specialty pharmacy services.

“Maria has been a steady and strong contributor at the Company for nearly eight years,” said Blair. “I know the impact Maria can have on business performance, and I have tremendous trust in her ability to lead our efforts to define a more effective pharmacy operating model that leads to a better participant experience and greater cost effectiveness.”

About InnovAge
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers, and government payors — “win.” As of June 30, 2024, InnovAge served approximately 7,020 participants across 20 centers in six states. https://www.innovage.com/.

Investor Contact:
Ryan Kubota
RKubota@InnovAge.com

Media Contact:
Lara Hazenfield
Lhazenfied@InnovAge.com

Forward-Looking Statements – Safe Harbor

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and other words and terms of similar meaning that they do not relate strictly to historical or current facts. Examples of forward-looking statements include statements regarding our expectations with respect to the Company’s new President and Chief Operating Officer; the effective transition and readjustment of responsibilities within the Company; and our expectations with respect to the Company’s ability to improve and grow. Important factors that could cause actual results to differ materially from those indicated in the forward-looking statements include, among others, our dependence on our senior management team and ability to retain skilled employees; failure to execute an orderly President and Chief Operating Officer transition; the impact of the transition on the Company, its employees and its suppliers; the viability of, and/or our failure to execute, our business strategy and our ability to realize expected results; and other risk factors identified in our SEC reports, including, our most recent Annual Report on Form 10-K and any subsequent Quarterly Report on Form 10-Q, in each case, as filed with the SEC.

Any forward-looking statement made by the Company is based on information currently available to us. Except as required by law, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, whether as a result of new information, future developments or otherwise.

This press release was published by a CLEAR® Verified individual.


FAQ

Who is the new President and COO of InnovAge (INNV)?

Michael Scarbrough is the new President and Chief Operating Officer of InnovAge (INNV), effective November 4th, 2024. He previously served as CEO of Optum at Home.

What is InnovAge's (INNV) current participant count and center locations?

As of June 30, 2024, InnovAge (INNV) serves approximately 7,020 participants across 20 centers in six states.

Who was appointed as President of Pharmacy Services at InnovAge (INNV)?

Maria Lozzano was promoted to President, Pharmacy Services at InnovAge (INNV), after serving as the company's Senior Vice President and Chief Business Development Operations Officer.

Why did InnovAge (INNV) separate the President and CEO positions?

InnovAge (INNV) separated the positions of President and CEO to better enable execution of strategic priorities.

InnovAge Holding Corp.

NASDAQ:INNV

INNV Rankings

INNV Latest News

INNV Stock Data

656.96M
20.21M
85.04%
11.9%
0.24%
Medical Care Facilities
Services-health Services
Link
United States of America
DENVER